Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 25% ± 7% | |
| epithelial cell | 5 studies | 36% ± 15% | |
| ciliated cell | 4 studies | 28% ± 9% | |
| capillary endothelial cell | 3 studies | 17% ± 1% | |
| kidney loop of Henle epithelial cell | 3 studies | 17% ± 0% | |
| retinal rod cell | 3 studies | 27% ± 1% | |
| intestinal crypt stem cell | 3 studies | 20% ± 5% | |
| basal cell | 3 studies | 28% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3016.61 | 1445 / 1445 | 100% | 21.20 | 183 / 183 |
| prostate | 100% | 3181.27 | 245 / 245 | 100% | 44.17 | 502 / 502 |
| lung | 100% | 2697.29 | 577 / 578 | 100% | 17.09 | 1154 / 1155 |
| brain | 100% | 2210.57 | 2641 / 2642 | 100% | 19.13 | 703 / 705 |
| kidney | 100% | 3930.08 | 89 / 89 | 100% | 25.34 | 898 / 901 |
| breast | 100% | 2491.64 | 459 / 459 | 100% | 25.69 | 1113 / 1118 |
| thymus | 100% | 3017.11 | 653 / 653 | 100% | 17.39 | 602 / 605 |
| ovary | 100% | 2176.19 | 180 / 180 | 99% | 11.92 | 427 / 430 |
| liver | 100% | 2321.86 | 226 / 226 | 99% | 14.17 | 401 / 406 |
| uterus | 100% | 2802.72 | 170 / 170 | 99% | 14.30 | 453 / 459 |
| bladder | 100% | 3038.19 | 21 / 21 | 99% | 14.93 | 497 / 504 |
| pancreas | 100% | 1488.14 | 327 / 328 | 99% | 18.23 | 176 / 178 |
| stomach | 100% | 3605.41 | 359 / 359 | 98% | 18.49 | 281 / 286 |
| intestine | 100% | 4008.72 | 966 / 966 | 98% | 17.65 | 514 / 527 |
| adrenal gland | 100% | 2875.49 | 258 / 258 | 97% | 15.62 | 222 / 230 |
| skin | 100% | 1913.84 | 1808 / 1809 | 93% | 16.49 | 438 / 472 |
| adipose | 100% | 2479.50 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3349.83 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 100% | 3394.19 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2456.48 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 13.17 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 10.47 | 1 / 1 |
| heart | 99% | 2728.56 | 856 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 93% | 7.57 | 27 / 29 |
| eye | 0% | 0 | 0 / 0 | 78% | 8.75 | 62 / 80 |
| peripheral blood | 33% | 504.18 | 306 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007266 | Biological process | Rho protein signal transduction |
| GO_0010596 | Biological process | negative regulation of endothelial cell migration |
| GO_0008593 | Biological process | regulation of Notch signaling pathway |
| GO_0030100 | Biological process | regulation of endocytosis |
| GO_0070373 | Biological process | negative regulation of ERK1 and ERK2 cascade |
| GO_0001937 | Biological process | negative regulation of endothelial cell proliferation |
| GO_1903671 | Biological process | negative regulation of sprouting angiogenesis |
| GO_0006605 | Biological process | protein targeting |
| GO_0016525 | Biological process | negative regulation of angiogenesis |
| GO_0005741 | Cellular component | mitochondrial outer membrane |
| GO_0005739 | Cellular component | mitochondrion |
| GO_0005515 | Molecular function | protein binding |
| Gene name | SYNJ2BP |
| Protein name | Synaptojanin-2-binding protein (Mitochondrial outer membrane protein 25) |
| Synonyms | OMP25 |
| Description | FUNCTION: Regulates endocytosis of activin type 2 receptor kinases through the Ral/RALBP1-dependent pathway and may be involved in suppression of activin-induced signal transduction. . |
| Accessions | ENST00000256366.6 P57105 |
